1. Home
  2. INUV vs LPCN Comparison

INUV vs LPCN Comparison

Compare INUV & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INUV
  • LPCN
  • Stock Information
  • Founded
  • INUV N/A
  • LPCN 1997
  • Country
  • INUV United States
  • LPCN United States
  • Employees
  • INUV N/A
  • LPCN N/A
  • Industry
  • INUV Advertising
  • LPCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • INUV Consumer Discretionary
  • LPCN Health Care
  • Exchange
  • INUV Nasdaq
  • LPCN Nasdaq
  • Market Cap
  • INUV 62.8M
  • LPCN 16.1M
  • IPO Year
  • INUV N/A
  • LPCN N/A
  • Fundamental
  • Price
  • INUV $4.86
  • LPCN $3.10
  • Analyst Decision
  • INUV Strong Buy
  • LPCN Strong Buy
  • Analyst Count
  • INUV 2
  • LPCN 2
  • Target Price
  • INUV $17.50
  • LPCN $9.00
  • AVG Volume (30 Days)
  • INUV 206.4K
  • LPCN 60.6K
  • Earning Date
  • INUV 08-07-2025
  • LPCN 08-07-2025
  • Dividend Yield
  • INUV N/A
  • LPCN N/A
  • EPS Growth
  • INUV N/A
  • LPCN N/A
  • EPS
  • INUV N/A
  • LPCN N/A
  • Revenue
  • INUV $93,478,114.00
  • LPCN $3,674,834.00
  • Revenue This Year
  • INUV $28.36
  • LPCN N/A
  • Revenue Next Year
  • INUV $12.18
  • LPCN N/A
  • P/E Ratio
  • INUV N/A
  • LPCN N/A
  • Revenue Growth
  • INUV 18.20
  • LPCN N/A
  • 52 Week Low
  • INUV $1.90
  • LPCN $2.68
  • 52 Week High
  • INUV $7.90
  • LPCN $8.23
  • Technical
  • Relative Strength Index (RSI)
  • INUV 67.48
  • LPCN 43.66
  • Support Level
  • INUV $3.30
  • LPCN $3.13
  • Resistance Level
  • INUV $5.24
  • LPCN $3.23
  • Average True Range (ATR)
  • INUV 0.38
  • LPCN 0.17
  • MACD
  • INUV 0.16
  • LPCN -0.01
  • Stochastic Oscillator
  • INUV 85.05
  • LPCN 15.69

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: